Eli Lilly & Co.: The Indianapolis drug...

Eli Lilly & Co.: The Indianapolis drug firm reported that third-quarter earnings climbed 24% from a year ago to a record $212.4 million. Sales totaled a record $1.05 billion, a gain of 11%. The results were attributed to higher volume in both pharmaceuticals and medical instruments.